$LMND

Peters John Sheldon sold $191K of LMND

Peters John Sheldon (Chief Insurance Officer) sold 3,608 shares of Lemonade, Inc. (LMND) at $52.94 ($0.19M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Peters John Sheldon
Published Jun 5, 2026, 9:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 9:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LMND
Neutral
medium confidence
Mentioned
$LMND
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LMNDNeutralLow
01

Why it matters

The disclosure provides incremental sentiment information but does not, by itself, change the fundamental outlook absent corroborating news.

02

Market read

A routine 10b5-1 insider sale in LMND; any trading impact is likely small unless part of a broader selling pattern.

03

What to watch

Traders may over-weight single Form 4 prints; better signal comes from patterns (multiple officers, repeated sales outside 10b5-1, or large option exercises/sales).

Relevance 6/10Novelty 3/10Timing: Filed after-hours/late day; reflects 2026-06-04 sale details.

Background

SEC Form 4 reports insider transactions; this one is an open-market sale by Lemonade’s Chief Insurance Officer under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$LMNDNeutralMedium confidence
Context

Lemonade COO sold 3,608 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosed via SEC Form 4.

Expected impact

Likely limited near-term impact; any reaction should be muted unless accompanied by unusual volume or follow-on disclosures.

Evidence & confidence

The filing is an ownership-change disclosure (not earnings/M&A/regulatory). The sale is explicitly under a pre-arranged 10b5-1 plan, which reduces interpretability as new negative information.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is on a pre-arranged 10b5-1 schedule, it may simply reflect routine liquidity rather than a view on fundamentals.

Key entities

  • Lemonade, Inc.

    Subject of the SEC Form 4 insider sale disclosure.

  • Peters John Sheldon

    Chief Insurance Officer who sold 3,608 shares.

Related articles

$LMNDMed

Lemonade Shares Slide After Results Fail to Meet High Investor Expectations

Lemonade, Inc. (NYSE:LMND) shares fell more than 7% in pre-market trading after the AI-powered insurance company released its second-quarter 2026 results, with investors reacting negatively despite revenue outperforming expectations. The sell-off reflected concerns that the company's outlook failed to justify the high expectations already priced into the stock, following a strong rally earlier in the year.

$LMNDMedAI 8/10

Lemonade Crashes As Customer Growth Miss Spooks Wall Street

Lemonade (LMND) shares fell about 18% in early trading after its Q2 customer growth missed Wall Street expectations. Customers rose 23% to 3.31 million versus a 3.33 million estimate. Revenue increased 79% to $294.4 million, adjusted EBITDA loss narrowed to $18.7 million, and gross loss ratio improved to 60%. Lemonade also announced a CFO transition.

$LMNDMedAI 8/10

Why Lemonade Stock Is Crashing Today

Lemonade (LMND) shares fell about 22% on Wednesday after the company reported Q2 results. Lemonade posted a net loss of $0.56 per share on $294.4 million revenue, matching analyst estimates, with revenue up 79%. It beat sales and gross earned premium targets, but full-year guidance missed on in-force premium, pressuring the stock.

$LMNDMedAI 8/10

Why Lemonade (LMND) Stock Is Nosediving

Lemonade (NYSE: LMND) shares fell 22.7% after the company issued a weaker-than-expected outlook and announced CFO Tim Bixby will step down at year-end, with Nick Stead taking over on Jan. 1, 2027. Revenue rose 79.4% to $294.4 million, but higher marketing costs and near-term expense pressure delayed operating leverage.